Author:
Ruan Yunfeng,Jiang Jie,Guo Liang,Li Yan,Huang Hailiang,Shen Lu,Luan Mengqi,Li Mo,Du Huihui,Ma Cheng,He Lin,Zhang Xiaoqing,Qin Shengying
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. National Cancer Institute. General Information About Non-Small Cell Lung Cancer (NSCLC),
http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page1
(published in 2014) Date of access 09/05/2015.
2. Bardelli, A. et al. Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers. Science 300, 949, doi: 10.1126/science.1082596 (2003).
3. Sawyers, C. L. Opportunities and challenges in the development of kinase inhibitor therapy for cancer. Genes Dev 17, 2998–3010, doi: 10.1101/gad.1152403 (2003).
4. Jorissen, R. N. et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284, 31–53 (2003).
5. Mayo, C. et al. Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications. Pharmacogenomics 13, 789–802, doi: 10.2217/pgs.12.54 (2012).